| Cod Nacion | Nro Definitivo | Des Nomco | Des Prese | Cod Vtm | Cod Vmp | Cod Vmpp | Des Dosific | Cod Forfar | Cod Forfar Simplificada | Cod Envase | Contenido | Unid Contenido | Nro Conte | Cod Atc | Sw Psicotropo | Sw Estupefaciente | Sw Afecta Conduccion | Sw Triangulo Negro | Url Fictec | Url Prosp | Sw Receta | Sw Generico | Sw Sustituible | Sw Envase Clinico | Sw Uso Hospitalario | Sw Diagnostico Hospitalario | Sw Tld | Sw Especial Control Medico | Sw Huerfano | Sw Base A Plantas | Laboratorio Titular | Laboratorio Comercializador | Fecha Autorizacion | Sw Comercializado | Cod Sitreg | Cod Sitreg Presen | Fecha Situacion Registro | Fec Sitreg Presen | Sw Tiene Excipientes Decl Obligatoria | Nro Pactiv | Fec Comer | Lista Psicotropo | Cod Nacionales Inactivos | Lista Estupefaciente | Hash | Last Modified | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 762536 | 88793 | GLICLAZIDA AUROVITAS 30 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | GLICLAZIDA AUROVITAS 30 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 60 comprimidos | 30 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88793/88793_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88793/88793_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-04-17 | 1 | 1 | 1 | 2023-04-18 | 2023-04-17 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 762537 | 88794 | GLICLAZIDA AUROVITAS 60 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | GLICLAZIDA AUROVITAS 60 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 60 comprimidos | 60 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88794/88794_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88794/88794_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 1 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-04-17 | 1 | 1 | 1 | 2023-04-18 | 2023-04-17 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 762670 | 88815 | MANIDIPINO AUROVITAS 10 MG COMPRIMIDOS EFG | MANIDIPINO AUROVITAS 10 MG COMPRIMIDOS EFG, 28 comprimidos | 10 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88815/88815_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88815/88815_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-04-27 | 1 | 1 | 1 | 2023-04-28 | 2023-04-27 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 762671 | 88816 | MANIDIPINO AUROVITAS 20 MG COMPRIMIDOS EFG | MANIDIPINO AUROVITAS 20 MG COMPRIMIDOS EFG, 28 comprimidos | 20 mg | 5 | 28 | 10 | 28 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88816/88816_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88816/88816_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-04-27 | 1 | 1 | 1 | 2023-04-28 | 2023-04-27 | 1 | 2023-12-11 | View Edit Delete | ||||||||||||
| 762956 | 88915 | SOLIFENACINA /TAMSULOSINA AUROVITAS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG | SOLIFENACINA /TAMSULOSINA AUROVITAS 6 MG/0,4 MG COMPRIMIDOS DE LIBERACION MODIFICADA EFG, 30 comprimidos | 0,4 mg/6 mg | 5 | 30 | 10 | 30 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88915/88915_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88915/88915_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-06-19 | 1 | 1 | 1 | 2023-06-20 | 2023-06-19 | 1 | 2024-03-13 | View Edit Delete | ||||||||||||
| 763350 | 86554 | IBUPROFENO AUROVITAS PHARMA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | IBUPROFENO AUROVITAS PHARMA 400 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 20 comprimidos | 400 mg | 5 | 20 | 10 | 20 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/86554/86554_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/86554/86554_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2022-02-07 | 1 | 1 | 1 | 2022-02-08 | 2023-09-04 | 1 | 2025-02-05 | View Edit Delete | ||||||||||||
| 763355 | 89037 | LEVETIRACETAM AUROVITAS 750 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG | LEVETIRACETAM AUROVITAS 750 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFG, 60 comprimidos | 750 mg | 5 | 60 | 10 | 60 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89037/89037_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89037/89037_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-09-06 | 1 | 1 | 1 | 2023-09-07 | 2023-09-06 | 1 | 2024-07-29 | View Edit Delete | ||||||||||||
| 763380 | 89045 | PIRFENIDONA AUROVITAS 267 MG COMPRIMIDOS EFG | PIRFENIDONA AUROVITAS 267 MG COMPRIMIDOS EFG, 63 comprimidos | 267 mg | 5 | 63 | 10 | 63 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89045/89045_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89045/89045_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-09-14 | 1 | 1 | 1 | 2023-09-16 | 2023-09-14 | 1 | 2024-08-28 | View Edit Delete | ||||||||||||
| 763381 | 89045 | PIRFENIDONA AUROVITAS 267 MG COMPRIMIDOS EFG | PIRFENIDONA AUROVITAS 267 MG COMPRIMIDOS EFG, 252 comprimidos | 267 mg | 5 | 252 | 10 | 252 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89045/89045_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89045/89045_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-09-14 | 1 | 1 | 1 | 2023-09-16 | 2023-09-14 | 1 | 2024-08-28 | View Edit Delete | ||||||||||||
| 763382 | 89046 | PIRFENIDONA AUROVITAS 801 MG COMPRIMIDOS EFG | PIRFENIDONA AUROVITAS 801 MG COMPRIMIDOS EFG, 84 comprimidos | 801 mg | 5 | 84 | 10 | 84 comprimidos | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89046/89046_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89046/89046_p.pdf | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-09-14 | 1 | 1 | 1 | 2023-09-16 | 2023-09-14 | 1 | 2024-08-28 | View Edit Delete | ||||||||||||
| 763699 | 89132 | AMOXICILINA/ÁCIDO CLAVULÁNICO AUROVITAS 875 MG/125 MG POLVO PARA SUSPENSIÓN ORAL EN SOBRES EFG | AMOXICILINA/ÁCIDO CLAVULÁNICO AUROVITAS 875 MG/125 MG POLVO PARA SUSPENSIÓN ORAL EN SOBRES EFG, 20 sobres | 875 mg/125 mg | 35 | 20 | 64 | 20 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89132/89132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89132/89132_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-11-03 | 1 | 1 | 1 | 2023-11-04 | 2023-11-03 | 1 | 2025-01-13 | View Edit Delete | ||||||||||||
| 763700 | 89132 | AMOXICILINA/ÁCIDO CLAVULÁNICO AUROVITAS 875 MG/125 MG POLVO PARA SUSPENSIÓN ORAL EN SOBRES EFG | AMOXICILINA/ÁCIDO CLAVULÁNICO AUROVITAS 875 MG/125 MG POLVO PARA SUSPENSIÓN ORAL EN SOBRES EFG, 30 sobres | 875 mg/125 mg | 35 | 30 | 64 | 30 sobres | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89132/89132_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89132/89132_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2023-11-03 | 1 | 1 | 1 | 2023-11-04 | 2023-11-03 | 1 | 2024-11-19 | View Edit Delete | ||||||||||||
| 764352 | 88048 | RIVASTIGMINA AUROVITAS SPAIN 13,3 MG/24 H PARCHES TRANSDERMICOS EFG | RIVASTIGMINA AUROVITAS SPAIN 13,3 MG/24 H PARCHES TRANSDERMICOS EFG, 60 sobres (2 x 30 ) parches transdermicos, (Papel/PET/PE/Al/LasPolD) | 13,3 mg/24 h | 35 | 60 | 28 | 60 sobres (2 x 30 ) parches transdermicos, (Papel/PET/PE/Al/LasPolD) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/88048/88048_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/88048/88048_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2022-08-25 | 1 | 1 | 1 | 2022-08-26 | 2024-02-16 | 0 | 2024-12-19 | View Edit Delete | ||||||||||||
| 764355 | 84207 | RIVASTIGMINA AUROVITAS SPAIN 9,5 MG/24 H PARCHES TRANSDERMICOS EFG | RIVASTIGMINA AUROVITAS SPAIN 9,5 MG/24 H PARCHES TRANSDERMICOS EFG, 60 sobres (2 X 30) parches transdérmicos, (Papel/PET/PE/Al/LasPolD) | 9,5 mg/24 h | 35 | 60 | 28 | 60 sobres (2 X 30) parches transdérmicos, (Papel/PET/PE/Al/LasPolD) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84207/84207_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84207/84207_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2019-07-24 | 1 | 1 | 1 | 2019-07-24 | 2024-02-16 | 0 | 2024-12-19 | View Edit Delete | ||||||||||||
| 764408 | 84206 | RIVASTIGMINA AUROVITAS SPAIN 4,6 MG/24 H PARCHES TRANSDERMICOS EFG | RIVASTIGMINA AUROVITAS SPAIN 4,6 MG/24 H PARCHES TRANSDERMICOS EFG, 30 parches transdérmicos (Papel/PET/PE/Al/LasPolD) | 4,6 mg/24 h | 35 | 30 | 28 | 30 parches transdérmicos (Papel/PET/PE/Al/LasPolD) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84206/84206_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84206/84206_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2019-07-24 | 1 | 1 | 1 | 2019-07-24 | 2024-02-22 | 0 | 2024-12-19 | View Edit Delete | ||||||||||||
| 765386 | 89711 | DEXKETOPROFENO AUROVITAS PHARMA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA | DEXKETOPROFENO AUROVITAS PHARMA 25 MG COMPRIMIDOS RECUBIERTOS CON PELÍCULA, 10 comprimidos | 25 mg | 5 | 10 | 10 | 10 comprimidos | 0 | 0 | 0 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89711/89711_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89711/89711_p.pdf | 0 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2024-07-15 | 1 | 1 | 1 | 2024-07-16 | 2024-07-15 | 1 | 2025-11-03 | View Edit Delete | ||||||||||||
| 765423 | 89720 | DIAZEPAM AUROVITAS 10 MG COMPRIMIDOS EFG | DIAZEPAM AUROVITAS 10 MG COMPRIMIDOS EFG, 30 comprimidos | 10 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89720/89720_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89720/89720_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2024-07-18 | 1 | 1 | 1 | 2024-07-19 | 2024-07-18 | 1 | 2025-12-09 | Lista IV | View Edit Delete | |||||||||||
| 765424 | 89721 | DIAZEPAM AUROVITAS 2,5 MG COMPRIMIDOS | DIAZEPAM AUROVITAS 2,5 MG COMPRIMIDOS, 40 comprimidos | 2,5 mg | 5 | 40 | 10 | 40 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89721/89721_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89721/89721_p.pdf | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2024-07-18 | 1 | 1 | 1 | 2024-07-19 | 2024-07-18 | 1 | 2025-09-15 | Lista IV | View Edit Delete | |||||||||||
| 765425 | 89722 | DIAZEPAM AUROVITAS 5 MG COMPRIMIDOS EFG | DIAZEPAM AUROVITAS 5 MG COMPRIMIDOS EFG, 30 comprimidos | 5 mg | 5 | 30 | 10 | 30 comprimidos | 1 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/89722/89722_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/89722/89722_p.pdf | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2024-07-18 | 1 | 1 | 1 | 2024-07-19 | 2024-07-18 | 1 | 2025-12-09 | Lista IV | View Edit Delete | |||||||||||
| 764518 | 84206 | RIVASTIGMINA AUROVITAS SPAIN 4,6 MG/24 H PARCHES TRANSDERMICOS EFG | RIVASTIGMINA AUROVITAS SPAIN 4,6 MG/24 H PARCHES TRANSDERMICOS EFG, 60 parches transdérmicos ( 2 x 30) (Papel/PET/PE/Al/LasPolD) | 4,6 mg/24 h | 35 | 60 | 28 | 60 parches transdérmicos ( 2 x 30) (Papel/PET/PE/Al/LasPolD) | 0 | 0 | 1 | 0 | https://cima.aemps.es/cima/pdfs/es/ft/84206/84206_ft.pdf | https://cima.aemps.es/cima/pdfs/es/p/84206/84206_p.pdf | 1 | 1 | 1 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 16109 | AUROVITAS SPAIN, S.A.U. | 2019-07-24 | 1 | 1 | 1 | 2019-07-24 | 2024-03-11 | 0 | 2024-12-19 | View Edit Delete |
Page 248 of 1036, showing 20 records out of 20704 total, starting on record 4941, ending on 4960